Evidence map›Paper›PMID 25971962›Full record

ArticleThe Journal of biological chemistry2015

Structural Characterization of Phosducin and Its Complex with the 14-3-3 Protein.

Miroslava Kacirova, Dalibor Kosek, Alan Kadek, Petr Man, Jaroslav Vecer, Petr Herman, Veronika Obsilova, Tomas Obsil

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Modulators of 14-3-3 Protein-Protein Interactions.Journal of medicinal chemistry · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Miroslava KacirovaFrom the Departments of Physical and Macromolecular Chemistry and the Institutes of Physiology and.
Dalibor KosekFrom the Departments of Physical and Macromolecular Chemistry and the Institutes of Physiology and.
Alan KadekMicrobiology,Czech Academy of Sciences, 14220 Prague, and Biochemistry Faculty of Science, Charles University in Prague, 12843 Prague.
Petr ManMicrobiology,Czech Academy of Sciences, 14220 Prague, and Biochemistry Faculty of Science, Charles University in Prague, 12843 Prague.
Jaroslav Vecerthe Institute of Physics, Faculty of Mathematics and Physics, Charles University in Prague, 12116 Prague, Czech Republic.
Petr Hermanthe Institute of Physics, Faculty of Mathematics and Physics, Charles University in Prague, 12116 Prague, Czech Republic.
Veronika Obsilovathe Institutes of Physiology and veronika.obsilova@fgu.cas.cz.
Tomas ObsilFrom the Departments of Physical and Macromolecular Chemistry and the Institutes of Physiology and obsil@natur.cuni.cz.
Czech Academy of Sciences, Institute of Physiology · CZCharles University · CZCzech Academy of Sciences · CZCzech Academy of Sciences, Institute of Physics · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosducin (Pdc), a highly conserved phosphoprotein involved in the regulation of retinal phototransduction cascade, transcriptional control, and modulation of blood pressure, is controlled in a phosphorylation-dependent manner, including the binding to the 14-3-3 protein. However, the molecular mechanism of this regulation is largely unknown. Here, the solution structure of Pdc and its interaction with the 14-3-3 protein were investigated using small angle x-ray scattering, time-resolved fluorescence spectroscopy, and hydrogen-deuterium exchange coupled to mass spectrometry. The 14-3-3 protein dimer interacts with Pdc using surfaces both inside and outside its central channel. The N-terminal domain of Pdc, where both phosphorylation sites and the 14-3-3-binding motifs are located, is an intrinsically disordered protein that reduces its flexibility in several regions without undergoing dramatic disorder-to-order transition upon binding to 14-3-3. Our data also indicate that the C-terminal domain of Pdc interacts with the outside surface of the 14-3-3 dimer through the region involved in Gtβγ binding. In conclusion, we show that the 14-3-3 protein interacts with and sterically occludes both the N- and C-terminal Gtβγ binding interfaces of phosphorylated Pdc, thus providing a mechanistic explanation for the 14-3-3-dependent inhibition of Pdc function.

Indexed as

14-3-3 ProteinsAmino Acid SequenceAnimalsBinding SitesEye ProteinsGTP-Binding Protein RegulatorsHumansModels, MolecularPhosphoproteinsPhosphorylationProtein BindingProtein Structure, TertiaryRats14-3-3 ProteinsEye ProteinsGTP-Binding Protein RegulatorsphosducinPhosphoproteinsYWHAZ protein, human14-3-3 proteinfluorescencehydrogen-deuterium exchangephosducinprotein complexprotein phosphorylationsmall-angle x-ray scattering (SAXS)

Identifiers

PMID25971962
PMCPMC4481224
OpenAlexW1958309108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.